• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Hemosiderosis causing liver cirrhosis in a patient with Hb S/beta thalassemia and no other known causes of hepatic disease.血红蛋白S/β地中海贫血患者出现血色素沉着症导致肝硬化,且无其他已知肝脏疾病病因。
Hippokratia. 2017 Jan-Mar;21(1):43-45.
2
Iron overload across the spectrum of non-transfusion-dependent thalassaemias: role of erythropoiesis, splenectomy and transfusions.非输血依赖型地中海贫血症中的铁过载:红细胞生成、脾切除术及输血的作用
Br J Haematol. 2017 Jan;176(2):288-299. doi: 10.1111/bjh.14373. Epub 2016 Dec 5.
3
Non-transferrin-bound labile plasma iron and iron overload in sickle-cell disease: a comparative study between sickle-cell disease and beta-thalassemic patients.非转铁蛋白结合的不稳定血浆铁和镰状细胞病中的铁过载:镰状细胞病与β地中海贫血病患者的对比研究。
Eur J Haematol. 2010 Jan 1;84(1):72-8. doi: 10.1111/j.1600-0609.2009.01342.x.
4
Splenectomy, iron overload and liver cirrhosis in beta-thalassemia major.重型β地中海贫血中的脾切除术、铁过载和肝硬化
Acta Haematol. 1976;56(3):142-50. doi: 10.1159/000207931.
5
Liver Cirrhosis in a Patient with Sickle Cell Trait (Hb Sβ Thalassemia) without Other Known Causes of Hepatic Disease.一例具有镰状细胞性状(Hb Sβ地中海贫血)且无其他已知肝脏疾病病因患者的肝硬化
Case Rep Gastroenterol. 2009 Sep 12;3(3):275-279. doi: 10.1159/000235235.
6
Mitapivat for sickle cell disease and thalassemia.米替膦酸治疗镰状细胞病和地中海贫血。
Drugs Today (Barc). 2023 Mar;59(3):125-134. doi: 10.1358/dot.2023.59.3.3521880.
7
Liver iron concentrations and urinary hepcidin in beta-thalassemia.β地中海贫血患者的肝脏铁浓度和尿铁调素
Haematologica. 2007 May;92(5):583-8. doi: 10.3324/haematol.10842.
8
Compound Heterozygosity of β-Thalassemia and the Sickle Cell Hemoglobin in Various Populations of Chhattisgarh State, India.印度恰蒂斯加尔邦不同人群中β地中海贫血与镰状细胞血红蛋白的复合杂合性
Hemoglobin. 2018 Mar;42(2):84-90. doi: 10.1080/03630269.2018.1483946.
9
Imbalance of erythropoiesis and iron metabolism in patients with thalassemia.地中海贫血患者的红细胞生成和铁代谢失衡。
Int J Med Sci. 2019 Jan 1;16(2):302-310. doi: 10.7150/ijms.27829. eCollection 2019.
10
Serum ferritin levels in thalassemias and the effect of splenectomy.地中海贫血患者的血清铁蛋白水平及脾切除术的影响。
Acta Haematol. 1981;66(4):244-50. doi: 10.1159/000207129.

引用本文的文献

1
Iron as a therapeutic target in chronic liver disease.铁作为慢性肝病的治疗靶点。
World J Gastroenterol. 2023 Jan 28;29(4):616-655. doi: 10.3748/wjg.v29.i4.616.
2
Sickle Hepatopathy.镰状细胞性肝病
J Clin Exp Hepatol. 2021 Jan-Feb;11(1):82-96. doi: 10.1016/j.jceh.2020.08.003. Epub 2020 Aug 9.

本文引用的文献

1
Acute and chronic hepatobiliary manifestations of sickle cell disease: A review.镰状细胞病的急慢性肝胆表现:综述
World J Gastrointest Pathophysiol. 2017 Aug 15;8(3):108-116. doi: 10.4291/wjgp.v8.i3.108.
2
Consequences and management of iron overload in sickle cell disease.镰状细胞病中铁过载的后果与管理
Hematology Am Soc Hematol Educ Program. 2013;2013:447-56. doi: 10.1182/asheducation-2013.1.447.
3
Transfusion therapy for sickle cell disease: a balancing act.镰状细胞病的输血治疗:一种平衡行为。
Hematology Am Soc Hematol Educ Program. 2013;2013:439-46. doi: 10.1182/asheducation-2013.1.439.
4
Iron overload in non-transfusion-dependent thalassemia: a clinical perspective.非输血依赖型地中海贫血中的铁过载:临床视角。
Blood Rev. 2012 Apr;26 Suppl 1:S16-9. doi: 10.1016/S0268-960X(12)70006-1.
5
Identification of TWSG1 as a second novel erythroid regulator of hepcidin expression in murine and human cells.在小鼠和人类细胞中鉴定TWSG1作为铁调素表达的第二种新型红细胞调节因子。
Blood. 2009 Jul 2;114(1):181-6. doi: 10.1182/blood-2008-12-195503. Epub 2009 May 4.
6
The congenital dyserythropoietic anemias.先天性红细胞生成异常性贫血
Hematol Oncol Clin North Am. 2009 Apr;23(2):283-306. doi: 10.1016/j.hoc.2009.01.010.
7
Recent advances in the understanding of inherited sideroblastic anaemia.遗传性铁粒幼细胞贫血认识方面的最新进展。
Br J Haematol. 2008 Oct;143(1):27-38. doi: 10.1111/j.1365-2141.2008.07290.x. Epub 2008 Jul 14.
8
Hepatic dysfunction in sickle cell disease: a new system of classification based on global assessment.镰状细胞病中的肝功能障碍:基于整体评估的新分类系统
Clin Gastroenterol Hepatol. 2007 Dec;5(12):1469-76; quiz 1369. doi: 10.1016/j.cgh.2007.08.009. Epub 2007 Sep 27.
9
Ineffective erythropoiesis in beta-thalassemia is characterized by increased iron absorption mediated by down-regulation of hepcidin and up-regulation of ferroportin.β地中海贫血中无效造血的特征是,通过铁调素下调和铁转运蛋白上调介导的铁吸收增加。
Blood. 2007 Jun 1;109(11):5027-35. doi: 10.1182/blood-2006-09-048868. Epub 2007 Feb 13.
10
Morbidity and mortality in chronically transfused subjects with thalassemia and sickle cell disease: A report from the multi-center study of iron overload.地中海贫血和镰状细胞病长期输血患者的发病率和死亡率:铁过载多中心研究报告
Am J Hematol. 2007 Apr;82(4):255-65. doi: 10.1002/ajh.20809.

血红蛋白S/β地中海贫血患者出现血色素沉着症导致肝硬化,且无其他已知肝脏疾病病因。

Hemosiderosis causing liver cirrhosis in a patient with Hb S/beta thalassemia and no other known causes of hepatic disease.

作者信息

Demosthenous C, Rizos G, Vlachaki E, Tzatzagou G, Gavra M

机构信息

1 Department of Internal Medicine, Papageorgiou General Hospital, Thessaloniki, Greece.

Department of Hematology and HCT Unit, George Papanicolaou General Hospital, Thessaloniki, Greece.

出版信息

Hippokratia. 2017 Jan-Mar;21(1):43-45.

PMID:29904256
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5997016/
Abstract

BACKGROUND

Hemosiderosis in the absence of blood transfusions has been encountered in conditions associated with ineffective erythropoiesis but not in sickle-cell disease (SCD). Description of the case: We report a case of a 34-year-old Caucasian male, with a history of SCD and beta thalassemia (Hb S/β-thal) who presented with acute painful crises. Despite never having received regular blood transfusions in the past, the patient demonstrated elevated ferritin levels and transferrin saturation of 83 %. Further evaluation revealed diffuse hepatocellular dysfunction and cirrhosis.

CONCLUSION

To the best of our knowledge, this is the first patient with Hb S/β-thal without a prior history of chronic blood transfusions or other predisposing factors for liver disease who developed hemosiderosis and cirrhosis. The pathomechanism, in this case, is thought to be related to increased duodenal iron uptake secondary to premature red cell precursor death. Further studies are required to characterize ineffective intramedullary erythropoiesis and iron metabolism better, and to improve the existing management guidelines of iron overload. The data reported herein suggest that patients with hemoglobinotpathies should be screened for iron overload regardless of transfusion history. HIPPOKRATIA 2017, 21(1): 43-45.

摘要

背景

在与无效红细胞生成相关的疾病中曾遇到过未输血情况下的含铁血黄素沉着症,但在镰状细胞病(SCD)中未见报道。病例描述:我们报告一例34岁的白种男性,有SCD和β地中海贫血(Hb S/β-地贫)病史,因急性疼痛危象就诊。尽管该患者过去从未接受过定期输血,但铁蛋白水平升高,转铁蛋白饱和度达83%。进一步评估发现弥漫性肝细胞功能障碍和肝硬化。

结论

据我们所知,这是首例既往无慢性输血史或其他肝病易感因素的Hb S/β-地贫患者发生含铁血黄素沉着症和肝硬化。该病例的发病机制被认为与早幼红细胞前体死亡继发十二指肠铁吸收增加有关。需要进一步研究以更好地描述无效的骨髓内红细胞生成和铁代谢,并改进现有的铁过载管理指南。本文报道的数据表明,无论输血史如何,血红蛋白病患者均应筛查铁过载。《希波克拉底》2017年,21(1): 43 - 45。